Trials / Completed
CompletedNCT01577069
Predictive Factors of the Treatment Failure in Hepatitis C Virus (HCV) Infected Patients Treated With Telaprevir
Predictive Factors of the Treatment Failure in HCV Mono-infected Patients Treated With Pegylated-interferon/Ribavirin/Telaprevir.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 73 (estimated)
- Sponsor
- Association HGE CHU Bordeaux Sud · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to 1- detect and quantify HCV-PI resistant mutants with ultra-deep pyrosequencing (UDPS) technology, 2 - detect SNPs in P-glyocoprotein and CYP3A genes, in HCV mono-infected patients under/after Telaprevir treatment.
Conditions
Timeline
- Start date
- 2011-02-01
- Primary completion
- 2013-01-01
- Completion
- 2013-01-01
- First posted
- 2012-04-13
- Last updated
- 2016-06-22
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01577069. Inclusion in this directory is not an endorsement.